Market Cap
$9.82B$212.12M-2.11%
Summary
- Current Value
- As of today, PCVX market cap is $10B, down -2.11% in the current trading session
- Category
- Based on its current market cap, PCVX falls into the Mid Cap category
- Historical Performance
- PCVX market cap is up +62.38% year-to-date, up +55.10% over the past 365 days
- All-Time High Comparison
- PCVX market cap is currently -33.08% below its historical high of $15B set on
- 3-Year Low Comparison
- PCVX market cap is +171.59% above its 3-year low of $4B reached on
- Sector Comparison
- PCVX market cap is higher than 90.36% of companies in Healthcare sector
Market Cap Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1D | 1M | 3M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $10B | -2.1% | -1.9% | +13.6% | +62.4% | +55.1% | +106.1% | +623.7% | |
| Price | $62.03 | -2.1% | -2.5% | +6.8% | +34.4% | +27.4% | +23.8% | +140.4% | |
| Shares Outstanding | 158.30M | +0.6% | – | – | – | +21.7% | +66.5% | +201.0% | |
| PE Ratio | - | – | – | – | – | – | – | – | |
| TTM Revenue | $0.00 | 0.0% | – | 0.0% | – | 0.0% | 0.0% | 0.0% | |
| TTM EPS | -$8.14 | -5.6% | – | -5.6% | – | -65.4% | -144.0% | -354.7% | |
| $8.75B | -2.4% | -2.2% | +20.4% | +90.0% | +86.0% | +149.1% | +710.6% | ||
| TTM Dividend | - | – | – | – | – | – | – | – | |
| TTM Net Income | -$1.15B | -7.9% | – | -7.9% | – | -74.8% | -283.4% | -1145.0% |
Market Cap Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1M | $11B | -9.6% | |
| 3M | $11B | -11.9% | |
| 6M | $11B | -11.9% | |
| 1Y | $11B | -11.9% | |
| 3Y | $15B | -33.1% | |
| 5Y | $15B | -33.1% | |
| All | $15B | -33.1% |
Market Cap Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1M | $9B | +4.0% | |
| 3M | $8B | +17.7% | |
| 6M | $7B | +49.7% | |
| 1Y | $6B | +75.4% | |
| 3Y | $4B | +171.6% | |
| 5Y | $926M | +960.5% | |
| All | $845M | +1062.7% |
Market Cap History
| Date | Value | Change |
|---|---|---|
| $10B | +62.4% | |
| $6B | -40.9% | |
| $10B | +70.7% | |
| $6B | +57.2% |
| Date | Value | Change |
|---|---|---|
| $4B | +202.0% | |
| $1B | -7.0% | |
| $1B | - |
FAQ
- What is the current market cap of PCVX?
- As of today, PCVX market cap is $10B
- What market cap category does PCVX fall into?
- Based on its current market cap, PCVX falls into the Mid Cap category
- What is PCVX market cap today change?
- PCVX market cap is down -2.11% today
- What is 1-year change in PCVX market cap?
- PCVX market cap is up +55.10% year-over-year
- How far is PCVX market cap from its all-time high?
- PCVX market cap is currently -33.08% below its historical high of $15B set on October 16, 2024
- How does PCVX market cap rank versus sector peers?
- PCVX market cap is higher than 90.36% of companies in Healthcare sector
Market Cap Formula
Market Cap = Price × Shares Outstanding
Data Sources & References
- PCVX Official Website vaxcyte.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1649094/000164909426000007/0001649094-26-000007-index.htm
- PCVX Profile on Yahoo Finance finance.yahoo.com/quote/PCVX
- PCVX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/pcvx
